Back

Effect of bivalirudin vs unfractionated heparin in transcatheter aortic valve implantation with balloon-expandable valves. The BRAVO-3 trial

27 August 2016 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Percutaneous structural heart interventions Percutaneous / endovascular treatment ESC Premium Access ESC Congress 2016

About the speaker

Photo
Professor Axel Hp Linke

Heart Center - University Hospital Dresden, Dresden (Germany)

18 More presentations in this session

Presentation thumbnail
Doctor S. Ramkumar (Melbourne, AU)
Abstract Slides
Presentation thumbnail
Doctor T. Lefevre (Massy, FR)
Abstract Slides
Presentation thumbnail
Doctor R. Scarsini (Verona, IT)
Abstract Slides
Presentation thumbnail
Mr F. Kortlandt (Nieuwegein, NL)
Abstract Slides
Presentation thumbnail
Doctor J. Carmo (Carnaxide, PT)
Abstract

Access the full session

Session thumbnail
Poster session 1 - Percutaneous structural heart interventions

The Event

Event poster

ESC Congress 2016

27 August 2016 11:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources